There was no statistically significant difference between the 2 groups according to the gene involved, with equal distribution of pathogenetic variant genes in BRCA1 and BRCA2, respectively, in patients developing cancer and those unaffected at time of observation. This evidence concerns the gene BRCA2 and cancer.